Top of page Skip navigation
  • JOIN US FOR THE BEST NIGHT IN THE BIOSCIENCE CALENDAR

    Network and connect with us

  • TABLES AND TICKETS NOW ON SALE

    Reserve your table or tickets today


We are delighted that the following organisations are joining us for the 2017 Gala Dinner

 
AbbVie 
AbbVie Ventures
Abingworth
ABPI
Absynth Biologics
Abzena
Abzena 
Acceleris Capital 
Accellerate Partners 
Accera 
Advent Life Sciences 
Aegerion Pharmaceutical 
Albion Ventures 
Albumedix
Albumedix 
Allergan Biologics 
Alzheimer's Research UK
Amgen 
Amicus Therapeutics
Amryt Pharma
Antibiotic Research UK
Apconix
Apex Consulting
Apollo Therapeutics
arGEN-X BV
Arnold & Porter Kaye Scholer 
Arthur J Gallagher
Artios Pharma 
Artios Pharma and TopiVert Pharma
Association of Medical Research Charities
Astellas Pharma
Astex Pharmaceuticals
AstraZeneca
Atopix Therapeutics 
Auspherix 
Austin Life Science Partners
Autifony Therapeutics
Autolus 
Avillion
Babraham Bioscience Technologies
Bayer AG
BBSRC
Beautiful Mind Investment
Bench International 
BenevolentAI
BioCity Group 
Bionow
BioPartner
Biopharm Services
Biotech Growth Trust
Bloomberg
Bradshaw Daniel 
Bristows 
BTG
BTG International 
BTG Management Services 
C4X Discovery 
Calchan 
Cambridge Enterprise
Cambridge Innovation Capital
Cambridge Science Centre
CamPhos Therapeutics
Cancer Reseacrh Technology
Cancer Research UK
Cannacord Genuity
Carrick Therapeutics 
Celixir
Cell and Gene Therapy Catapult
Cell Medica
CellCentric 
CellCentric and BIA Board
Celleron Therapeutics 
Charles River Laboratories
Charles Russell Speechlys
Chevrelles Consulting
Circassia Pharmaceuticals 
CMS Cameron McKenna
CN Bio Innovations
Concepta Diagnostics 
Confluence Tax 
Consilient Health 
Consilium Strategic Communications
Consort Medical 
Convergence Pharmaceuticals
Cooley 
CooperVision 
Coulter Partners
Covington & Burling 
Crescendo Biologics
CRUK-MedImmune Alliance Laboratory
CVC Capital Partners
Cypralis
Dementia Discovery Fund
Denceptor
Department for Business, Energy and Industrial Strategy
Department of Health
Desktop Genetics  
Dimension Therapeutics
Discuva 
Edison
Elands & Partners
Eli Lilly and Company
Enterprise Therapeutics
Epidarex Capital
EPSRC
EuropaBio
                                                     
                                                     
European Medicines Agency
Evelo Biosciences
Evercore Partners International
Evgen Pharma 
Evotec
Fidelta
Fieldfisher
Financial Times
Finncapp
Finnegan Europe 
Finnegan, Henderson, Farabow, Garrett & Dunner
Fountain Healthcare
F-Prime Capital
Freeline Therapeutics
F-star Biotechnology 
FTI Consulting
FUJIFILM Diosynth Biotechnologies
GE Healthcare
Genomics England
Gentronix 
GlaxoSmithKline
Globe Life Sciences
Gowling WLG (UK) 
GreyRigge Associates
GW Pharmaceuticals
Harwell Campus
Healthcap
HealX  
Heptares Therapeutics 
Herbert Smith Freehills
Horizon Discovery Group  
Hume Brophy
hVIVO
Hyper Recruitment Solutions 
Ieso Digital Health
Imanova 
Immunocore 
Imperial College
Imperial Innovations
Inhibox 
Inivata 
Innovate UK
Inside Biometrics
Instinctif
Institute of Cancer Research
IP Group
Ipsen
Ixico
Jagiellonian University
Jaytee Biosciences
Jefferies International 
Johnson & Johnson
Johnson & Johnson Innovation
Kalvista Pharmaceuticals
Karus Therapeutics
Kesios Therapeutics
Kinapse 
King's College London
Klein-Edmonds Associates
Koi Consulting Partners
Kurma Partners
Kymab
Kymab 
Lancea Partners
Life Science Biznes Consulting 
Life Sciences Organisation
London Stock Exchange Group
Mallinckrodt Pharmaceuticals
Manchester Science Park
Medical Research Council
Medicines and Healthcare products Regulatory Agency
Medicines Discovery Catapult
Medicxi
MedImmune
MediWales
Merck
Merck Ventures
Mereo BioPharma
Microbiotica 
Miltenyi Biotec 
Mission Therapeutics 
Modern Biosciences
Modulate Therapeutics 
Molecular Partners
MRC Technology
MSD
Mundipharma
Neem Biotech 
Nerre Therapeutics
Neuro-Bio 
NHS Blood and Transplant
Norgine
Northern Health Science Alliance
Northland Capital
Northridge Advisory
Novasecta 
Novo Seeds
Numis Securities
Odgers Berndtson
Office for Life Sciences
Olswang
One Nucleus
OrbiMed
Orchard Therapeutics
    
                                 
Osborne Clarke
Owlstone Medical 
Oxford Biodynamics
Oxford BioMedica
Oxford Sciences Innovation 
OxSonics 
OxSyBio
Pall Life Sciences
Parkinson's UK
Parkwalk Advisors
Peel Hunt
Peptinnovate 
Perscitus 
Pfizer 
Pharma Intelligence
Pharmacyclics
Pharming Group 
Physiomics 
Pinsent Masons
Pinsent Masons 
Polar Capital
Polar Capital and BIA Board
Potter Clarkson 
Powell Gilbert 
PsiOxus Therapeutics
PwC
Quanta Fluid Solutions
RBC Capital Markets
Redx Pharma 
ReNeuron
Repositive 
Sagitarius 
Sainsbury's
Sanger Institute
Sanofi
Scancell Holdings 
Scottish Development International
SCRIP Intelligence
Seneca Partners
SenzaGen  
Sequana Medical
SGC, Oxford University
Shield Therapeutics
Shore Capital
Silence Therapeutics
Silicon Valley Bank
Simmons & Simmons 
Sixth Element Capital
Smart Healthcare Consulting
Sofinnova Partners
Spencer Stuart
Stevenage Bioscience Catalyst
Stevens & Bolton 
Stifel
Storm Therapeutics
Stratagem IPM 
Stratophase
Summit Therapeutics 
Sunday Times
SV Life Sciences
Symbiosis Pharmaceutical Services 
Syncona Investment Management 
Syncona Partners
Syngenta
Synthace 
Takeda Pharmaceuticals
Talentmark
Talisman
Taylor Wessing 
Tessera Investment Partners
Teva Pharmaceuticals
The Communications Strategy Group 
The Francis Crick Institute
The Institute of Cancer Research
The RSA Group
Therakind
Topivert
Touchlight Genetics
Touchstone Innovations
Tusk Therapeutics 
TxCell 
UCB
UCL Business
University College London
University of Cambridge
University of Glasgow
University of Kent
University of Manchester
University of Nottingham
University of Oxford
University of Sussex
Val Jones PR 
ValiRx 
Vectura Group 
Vernalis
Verona Pharma
Vertex Pharmaceuticals (Europe) 
Visus Nano
VWR International
Wall Street Journal
Withers & Rogers
Woodford Investment Fund
Woodford Investment Management